Occurrence and pattern of cognitive deficits in prodromal Parkinson’s disease
Objective: To assess a possible cognitive impairment and its specific profile in the prodromal phase of Parkinson's disease (PD). Background: Cognitive impairment is common in…Plasma ceramides and glucosylceramides predict cognitive decline among cognitively normal Parkinson’s disease patients
Objective: To determine whether plasma ceramides, glucosylceramides, and their ratios predict cognitive decline among cognitively normal Parkinson's disease (PD) patients. Background: There are no biomarkers…Attention and dopamine: Increased distractibility in Parkinson’s disease
Objective: To determine the interactions between dopamine, Working Memory(WM) and Attentional Control(AC) in Parkinson's disease(PD) patients. Background: WM impairment is common in PD. Studies have…Psychiatric manifestations in the initial motor stage of Parkinson’s disease
Objective: To estimate the prevalence and correlates of neuropsychiatric symptoms (NPS) in a cohort of consecutive patients with Parkinson's disease (PD) recruited in the initial…Vitamin D in early Parkinson’s disease
Objective: To determine serum 25-hydroxy vitamin D (25OHD) concentration at diagnosis and 18 months in incident Parkinson's disease (PD) compared to controls and to investigate…Verb naming in hypokinetic and hyperkinetic movement disorders: Preliminary results
Objective: To investigate verb naming differences in hypokinetic (Parkinson's disease, PD) and hyperkinetic (primary cervical dystonia, PCD) movement disorders; and to determine whether different effects…Urate and homocysteine: Changes in motor and cognitive symptoms in newly diagnosed Parkinson’s disease
Objective: 1) To determine serum urate and homocysteine concentration at baseline, 18 and 36 months in control and PD participants. 2) To determine if urate…Emotional modulation of the startle reflex in essential tremor: Evidence of altered cerebellar input into limbic circuitry?
Objective: To examine whether Essential Tremor (ET) is associated with subtle changes in emotion processing, in parallel with those observed in the cognitive domain, using…Effects of zonisamide on dementia with Lewy bodies (DLB): A post-hoc analysis of phase 2 study for parkinsonism in DLB patients
Objective: To clarify the effects of zonisamide (ZNS) on the core symptoms of dementia with Lewy bodies (DLB), we performed a post-hoc analysis using data…Relationship of MDS-UPDRS non-motor symptoms to cognitive functioning in patients with Parkinson’s disease
Objective: To evaluate the relationship among individual items from the MDS-UPDRS Part I and measures of cognitive functioning in patients with PD. Background: Non-motor symptoms…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.